3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Withdrawn
1
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
10
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Lung Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Tobacco Use Disorder
1
Recurrence
1
Precancerous Conditions
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Kidney Neoplasms
1
Hirschsprung Disease
1
Glioma
1
Ganglion Cysts
1
Gallbladder Neoplasms
1
Endometrial Neoplasms
1
Interventions
Cisplatin
44
Paclitaxel
21
Radiotherapy
20
Brachytherapy
19
Carboplatin
18
Bevacizumab
7
Drug Therapy
6
camrelizumab
5
toripalimab
4
nimotuzumab
4
Radiation
4
Neoadjuvant Therapy
4
Gemcitabine
4
tislelizumab
3
sintilimab
3
pembrolizumab
3
apatinib
3
Vaccines
3
TP protocol
3
Surgical Procedures, Operative
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
nedaplatin
2
fludarabine
2
endostar protein
2
anlotinib
2
Topotecan
2
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Mindfulness
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Cervical Neoplasms
×
Immunohistochemistry
×
Clear all
NCT06147960
2023-11-28
EPIcol
Centre Hospitalier Universitaire de NÄ«mes
Unknown
180 enrolled